These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 11689430)
1. Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta. Murata S; Udono H; Tanahashi N; Hamada N; Watanabe K; Adachi K; Yamano T; Yui K; Kobayashi N; Kasahara M; Tanaka K; Chiba T EMBO J; 2001 Nov; 20(21):5898-907. PubMed ID: 11689430 [TBL] [Abstract][Full Text] [Related]
2. A role for the proteasome regulator PA28alpha in antigen presentation. Groettrup M; Soza A; Eggers M; Kuehn L; Dick TP; Schild H; Rammensee HG; Koszinowski UH; Kloetzel PM Nature; 1996 May; 381(6578):166-8. PubMed ID: 8610016 [TBL] [Abstract][Full Text] [Related]
3. The proteasome regulator PA28alpha/beta can enhance antigen presentation without affecting 20S proteasome subunit composition. Schwarz K; Eggers M; Soza A; Koszinowski UH; Kloetzel PM; Groettrup M Eur J Immunol; 2000 Dec; 30(12):3672-9. PubMed ID: 11169410 [TBL] [Abstract][Full Text] [Related]
4. Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells. Sun Y; Sijts AJ; Song M; Janek K; Nussbaum AK; Kral S; Schirle M; Stevanovic S; Paschen A; Schild H; Kloetzel PM; Schadendorf D Cancer Res; 2002 May; 62(10):2875-82. PubMed ID: 12019167 [TBL] [Abstract][Full Text] [Related]
5. Growth retardation in mice lacking the proteasome activator PA28gamma. Murata S; Kawahara H; Tohma S; Yamamoto K; Kasahara M; Nabeshima Y; Tanaka K; Chiba T J Biol Chem; 1999 Dec; 274(53):38211-5. PubMed ID: 10608895 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope. Schwarz K; van Den Broek M; Kostka S; Kraft R; Soza A; Schmidtke G; Kloetzel PM; Groettrup M J Immunol; 2000 Jul; 165(2):768-78. PubMed ID: 10878350 [TBL] [Abstract][Full Text] [Related]
7. Impaired immunoproteasome assembly and immune responses in PA28-/- mice. Preckel T; Fung-Leung WP; Cai Z; Vitiello A; Salter-Cid L; Winqvist O; Wolfe TG; Von Herrath M; Angulo A; Ghazal P; Lee JD; Fourie AM; Wu Y; Pang J; Ngo K; Peterson PA; Früh K; Yang Y Science; 1999 Dec; 286(5447):2162-5. PubMed ID: 10591649 [TBL] [Abstract][Full Text] [Related]
8. PI31 is a modulator of proteasome formation and antigen processing. Zaiss DM; Standera S; Kloetzel PM; Sijts AJ Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14344-9. PubMed ID: 12374861 [TBL] [Abstract][Full Text] [Related]
9. Structural plasticity of the proteasome and its function in antigen processing. Groettrup M; van den Broek M; Schwarz K; Macagno A; Khan S; de Giuli R; Schmidtke G Crit Rev Immunol; 2001; 21(4):339-58. PubMed ID: 11922078 [TBL] [Abstract][Full Text] [Related]
10. The proteasome activator 11 S REG (PA28) and class I antigen presentation. Rechsteiner M; Realini C; Ustrell V Biochem J; 2000 Jan; 345 Pt 1(Pt 1):1-15. PubMed ID: 10600633 [TBL] [Abstract][Full Text] [Related]
11. Tissue distribution of constitutive proteasomes, immunoproteasomes, and PA28 in rats. Noda C; Tanahashi N; Shimbara N; Hendil KB; Tanaka K Biochem Biophys Res Commun; 2000 Oct; 277(2):348-54. PubMed ID: 11032729 [TBL] [Abstract][Full Text] [Related]
12. PA28alphabeta double and PA28beta single transfectant mouse B8 cell lines reveal enhanced presentation of a mouse cytomegalovirus (MCMV) pp89 MHC class I epitope. Stohwasser R; Soza A; Eggers M; Koszinowski UH; Kloetzel PM Mol Immunol; 2000; 37(1-2):13-9. PubMed ID: 10781831 [TBL] [Abstract][Full Text] [Related]
13. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation. López D; Del Val M J Immunol; 1997 Dec; 159(12):5769-72. PubMed ID: 9550370 [TBL] [Abstract][Full Text] [Related]
14. Autoimmune response to proteasome activator 28alpha in patients with connective tissue diseases. Matsushita M; Takasaki Y; Takeuchi K; Yamada H; Matsudaira R; Hashimoto H J Rheumatol; 2004 Feb; 31(2):252-9. PubMed ID: 14760793 [TBL] [Abstract][Full Text] [Related]
15. Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. Khan S; van den Broek M; Schwarz K; de Giuli R; Diener PA; Groettrup M J Immunol; 2001 Dec; 167(12):6859-68. PubMed ID: 11739503 [TBL] [Abstract][Full Text] [Related]
16. PA28 modulates antigen processing and viral replication during coxsackievirus B3 infection. Respondek D; Voss M; Kühlewindt I; Klingel K; Krüger E; Beling A PLoS One; 2017; 12(3):e0173259. PubMed ID: 28278207 [TBL] [Abstract][Full Text] [Related]
17. Modulation of the PA28alpha-20S proteasome interaction by a peptidyl alcohol. Wilk S; Chen WE; Magnusson RP Arch Biochem Biophys; 1999 Feb; 362(2):283-90. PubMed ID: 9989937 [TBL] [Abstract][Full Text] [Related]
18. Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the 'PrOxI' hypothesis. Teoh CY; Davies KJ Arch Biochem Biophys; 2004 Mar; 423(1):88-96. PubMed ID: 14871471 [TBL] [Abstract][Full Text] [Related]
19. The ubiquitin-proteasome system plays essential roles in presenting an 8-mer CTL epitope expressed in APC to corresponding CD8+ T cells. Duan X; Hisaeda H; Shen J; Tu L; Imai T; Chou B; Murata S; Chiba T; Tanaka K; Fehling HJ; Koga T; Sueishi K; Himeno K Int Immunol; 2006 May; 18(5):679-87. PubMed ID: 16569681 [TBL] [Abstract][Full Text] [Related]
20. Properties of the beta subunit of the proteasome activator PA28 (11S REG). Wilk S; Chen WE; Magnusson RP Arch Biochem Biophys; 2000 Dec; 384(1):174-80. PubMed ID: 11147828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]